medigraphic.com

2018, Number 2

<< Back Next >>

Enf Infec Microbiol 2018; 38 (2)

Zika virus in America: clinical and epidemiological behavior

Zuluaga GM, Jaramillo JLI, Ruiz MC

Language: Spanish
References: 47
Page: 56-63
PDF size: 184.88 Kb.


ABSTRACT

The Zika virus is an arbovirus belonging to the Flaviviridae family, which has been known since 1947. Only since 2013 it had been reported in some studies in Asian and African countries. So still many unknown aspects regarding their virulence and pathophysiology. Transmission routes are not clear, but has been described the vector-borne, vertical and sexual transmission. In Colombia, up to epidemiological week four of 2016, 25 645 cases of Zika had been reported, including 1 331 laboratory confirmed cases, with a higher number of cases reported in North Santander. We show a historical review and the virology aspects, pathogenesis, epidemiology, clinical manifestations, complications, prevention and management of the infection by Zika virus.


REFERENCES

  1. Falcao, M.B., Cimerman, S., Luz, K.G., Chebabo, A., Brigido, H.A., Lobo, I.M., Timerman, A., Angerami, R.N., Da Cunha, C.A., Bacha, H.A., Alves, J.R., Barbosa, A.N., Teixeira, R.F., Weissmann, L., Oliveira, P.R., Cyrillo, M.A. y Bandeira, A.C., “Management of infection by the Zika virus”, Ann Clin Microbiol Antimicrob, 2016, 15 (1): 57.

  2. Li, H., Saucedo-Cuevas, L., Shresta, S. y Gleeson, J.G., “The neurobiology of Zika virus”, Neuron, 2016, 92 (5): 949-958.

  3. Wikan, N. y Smith, D.R., “Zika virus from a Southeast Asian perspective”, Asian Pac J Med, 2017, 10 (1): 1-5.

  4. Lessler, J., Chaisson, L.H., Kucirka, L.M., Bi, Q., Grantz, K., Salje, H., Carcelen, A.C., Ott, C.T., Sheffield, J.S., Ferguson, N.M., Cummings, D.A., Metcalf, C.J. y Rodríguez- Barraquer, I., “Assessing the global threat from Zika virus”, Science, 2016, 12: 353.

  5. Althouse, B.M., Vasilakis, N., Sall, A.A., Diallo, M., Weaver, S.C. y Hanley, K.A., “Potential for Zika virus to establish a sylvatic transmission cycle in the Americas”, plos Negl Trop Dis, 2016, 15: 10 (12): e0005055.

  6. He, A., Brasil, P., Siqueira, A.M., Calvet, G.A. y Kwatra, S.G., “The emerging Zika virus threat: a guide for dermatologists”, Am J Clin Dermatol, 2017, 18 (2): 231-236.

  7. Duffy, M.R., Chen, T.-H., Hancock, W.T., Powers, A.M., Kool, J.L., Lanciotti, R.S. et al., Zika virus outbreak on Yap Island, Federated States of Micronesia”, N Engl J Med, 2009, 360 (24): 2536-2543.

  8. Cao-Lormeau, V.-M., Roche, C., Teissier, A., Robin, E., Berry, A.-L., Mallet, H.-P. et al., Zika virus, French Polynesia, South Pacific 2013”, Emerg Infect Dis, 2014, 20 (6): 1085-1086.

  9. European Center for Disease Prevention and Control, Rapid risk assessment. Zika virus infection outbreak, French Polynesia, 2014.

  10. Musso, D., Nilles, E.J. y Cao-Lormeau, V.-M., “Rapid spread of emerging Zika virus in the Pacific area”, Clin Microbiol Infect, 2014, 20 (10): 595-596.

  11. Fauci, A.S. y Morens, D.M., “Zika virus in the Americas. Yet another arbovirus threat”, N Engl J Med, 2016, 374 (7): 601-604.

  12. Campos, G.S., Bandeira, A.C. y Sardi, S.I., “Zika virus outbreak, Bahia, Brazil”, Emerg Infect Dis, 2015, 21 (10): 1885-1886.

  13. Ye, Q., Liu, Z.Y., Han, J.F., Jiang, T., Li, X.F. y Qin, C.F., “Genomic characterization and phylogenetic analysis of Zika virus circulating in the Americas”, Infect Genet Evol, 2016, 43: 43-49.

  14. Kuno, G. y Chang, G.J., “Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses”, Arch Virol, 2007, 152: 687-696.

  15. Lanciotti, R.S., Kosoy, O.L., Laven, J.J., Vélez, J.O., Lambert, A.J. et al., “Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007”, Emerg Infect Dis, 2008, 14: 1232-1239.

  16. Haddow, A.D., Schuh, A.J., Yasuda, C.Y., Kasper, M.R., Hang, V. y Guzmán, H., “Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage”, plos Negl Trop Dis, 2012, 6 (2): e1477.

  17. Enfissi, A., Codrington, J., Roosblad, J., Kazanji, M. y Rousset, D., “Zika virus genome from the Americas”, Lancet, 2016, 387 (10015): 227-228.

  18. Besnard, M., Lastère, S., Teissier, A., Cao-Lormeau, V.M. y Musso, D., “Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014”, Euro Surveill, 2014, 19 (13): pii = 20751.

  19. Leung, G.H., Baird, R.W., Druce, J. y Ansley, N.M., “Zika virus infection in Australia following a monkey bite in Indonesia”, Southeast Asian J Trop Med Public Health, 2015, 46 (3): 460-464.

  20. Musso, D., Roche, C., Robin, E., Nhan, T., Teissier, A. y Cao-Lormeau, V.M., “Potential sexual transmission of Zika virus”, Emerg Infect Dis, 2015, 21 (2): 359-361.

  21. Dupont-Rouzeyrol, M., O’Connor, O., Calvez, E., Daures, M., John, M., Grangeon, J.P. et al., “Co-infection with Zika and dengue viruses in 2 patients, New Caledonia, 2014”, Emerg Infect Dis, 2015, 21 (2): 381-382.

  22. Briant, L., Desprès, P., Choumet, V. y Missé, D., “Role of skin immune cells on the host susceptibility to mosquito- borne viruses”, Virology, 2014, 464-465: 26-32. Disponible en: http://dx.doi.org/10.1016/j.virol.2014.06.023.

  23. Hamel, R., Dejarnac, O., Wichita, S., Ekchariyawat, P., Neyret, A., Luplertop, N. et al., “Biology of Zika virus infec- tion in humanskin cells”, J Virol, 2015, 89 (17), 8880-8896.

  24. Catrín, L., Larre, P., Leparc-Goffart, I., Lastere, S., Valour, F., Baudouin, L. et al., “Zika virus infection complicated by Guillain-Barré syndrome: case report, French Polynesia, december 2013”, Euro Surveil, 2014, 19 (9): 1-3.

  25. Centers of Disease Control and Prevention (cdc), “Areas with Zika”. Disponible en: http://www.cdc.gov/zika/geo/ index.html.

  26. Campos, G.S., Bandeira, A.C. y Sardi, S.I., “Zika virus outbreak, Bahia, Brazil”, Emerg Infect Dis, 2015, 21 (10): 1885-1886.

  27. Lowe, R., Barcellos, C., Coelho, C.A., Bailey, T.C., Coelho, G.E. y Graham, R., “Dengue outlook for the world cup in Brazil: an early warning model framework driven by real-time seasonal climate forecasts”, Lancet Infect Dis, 2014, 14 (7): 619-626.

  28. Gautret, P. y Simon, F., “Dengue, chikungunya and Zika and mass gatherings: what happened in Brazil, 2014”, Travel Med Infect Dis, 2016, 14 (1): 7-8.

  29. Centers of Disease Control and Prevention (cdc), “Zika virus spreads to new areas: region of the Americas, May 2015-January 2016. Disponible en: http://www.cdc.gov/ mmwr/volumes/65/wr/mm6503e1.htm.

  30. Organización Mundial de la Salud (oms), “Weekly epidemiological record”, 2015, 90: 609-616.

  31. Organización Panamericana de la Salud (ops)-Organización Mundial de la Salud (oms), Epidemiological update: neurological syndrome, congenital anomalies and Zika virus infection, ops-oms, 2016, pp. 1-8.

  32. Instituto Nacional de Salud, Semana epidemiológica número 52 de 2015 (27 dic.-02 ene.), bes, 2015, 1-72.

  33. Ministerio de Salud, Circular Conjunta Externa No. 00000043 octubre 14 de 2015, Instrucciones para la vigilancia en salud pública, atención clínica, prevención y control frente a la posible introducción del virus Zika (zikv) en Colombia.

  34. Yasri, S. y Wiwanitkit, J., “New human pathogenic dengue like virus infections (Zika, Alkhumraand Mayaro viruses): a short review”, Asian Pac J Trop Dis, 2015, 5 (1): S31-S32.

  35. Ioos, S., Mallet, H.P., Leparc-Goffart, I., Gauthier, V., Cardoso, T. y Herida, M., “Current Zika virus epidemiology and recent epidemics”, Médecine et Maladies Infectieuses, 2014, 44: 302-307.

  36. Zammarchi, L., Stellaa, G., Mantellaa, A., Bartolozzib, D., Tappec, D., Güntherc, S. et al., Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications”, J Clin Virol, 2015, 63: 32-35.

  37. Christo, P., “Encephalitis by dengue virus and other arboviruses”, Arq Neuropsiquiatr, 2015, 73 (8): 641-643.

  38. Mattar, S. y González, M., “El turno ahora es para el virus Zika”, Rev mvz Córdoba, 2015, 20 (2): 4511-4512.

  39. Lanciotti, R.S., Kosoy, O.L., Laven, J.J., Vélez, J.O., Lambert, A.J., Johnson, A.J. et al., “Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007”, Emerg Infect Dis, 2008, 14: 1232-1236.

  40. Organización Panamericana de la Salud (ops), Preliminary guidelines for the surveillance of microcephaly in newborns in settings with risk of Zika virus circulation, 2016, 1-13. Disponible en: http://www.paho.org/hq/ index.php?option=com_docman&task=doc_view&Itemid= 270&gid=33000. (Consultado: 2 de febrero 2016).

  41. Samarasekera, U. y Triunfol, M., “Concern over Zika virus grips the world”, Lancet, 2016, 387 (10018): 521-524.

  42. Tetro, J.A., “Zika and microcephaly: causation, correlation, or coincidence?”, Microbes Infect”, 2016, 16: pii S1286-4579.

  43. Mlakar, J., Korva, M., Tul, S., Popovic, M. et al., “Zika virus associated with microcephaly”, N Eng J Med, 2016, 374: 951-958.

  44. Brasil, P., Pereira, J., Raja, C., Damansceno, L. et al., “Zika virus infection in pregnant women in Rio de Janeiro. Preliminary report”, N Eng J Med, 2016, doi: 10.1056.

  45. Cao Lormeau, V.M., Blake, A., Mons, S., Lastere, S. et al., “Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study”, Lancet, 2016, pii: S0140-6736(16)00562-6.

  46. Organización Mundial de la Salud (oms), “Zika virus”. Disponible en: http://www.who.int/mediacentre/factsheets/ zika/en/. (Consultado: 2 de febrero de 2016.) Sanofi Pasteur, Sanofi Pasteur to leverage its strong vaccine legacy in Zika vaccine. Disponible en: http://www.

  47. sanofipasteur.com/en/Documents/PDF/PR/Zika%20Program% 20ENG.pdf. (Consultado: 14 de marzo de 2016).




2020     |     www.medigraphic.com